Siwy, J.; Keller, F.; Banasik, M.; Peters, B.; Dudoignon, E.; Mebazaa, A.; Gülmez, D.; Spasovski, G.; Lazo, M.S.; Rajzer, M.W.;
et al. Mortality Risk and Urinary Proteome Changes in Acute COVID-19 Survivors in the Multinational CRIT-COV-U Study. Biomedicines 2024, 12, 2090.
https://doi.org/10.3390/biomedicines12092090
AMA Style
Siwy J, Keller F, Banasik M, Peters B, Dudoignon E, Mebazaa A, Gülmez D, Spasovski G, Lazo MS, Rajzer MW,
et al. Mortality Risk and Urinary Proteome Changes in Acute COVID-19 Survivors in the Multinational CRIT-COV-U Study. Biomedicines. 2024; 12(9):2090.
https://doi.org/10.3390/biomedicines12092090
Chicago/Turabian Style
Siwy, Justyna, Felix Keller, Mirosław Banasik, Björn Peters, Emmanuel Dudoignon, Alexandre Mebazaa, Dilara Gülmez, Goce Spasovski, Mercedes Salgueira Lazo, Marek W. Rajzer,
and et al. 2024. "Mortality Risk and Urinary Proteome Changes in Acute COVID-19 Survivors in the Multinational CRIT-COV-U Study" Biomedicines 12, no. 9: 2090.
https://doi.org/10.3390/biomedicines12092090
APA Style
Siwy, J., Keller, F., Banasik, M., Peters, B., Dudoignon, E., Mebazaa, A., Gülmez, D., Spasovski, G., Lazo, M. S., Rajzer, M. W., Fuławka, Ł., Dzitkowska-Zabielska, M., Mischak, H., Hecking, M., Beige, J., Wendt, R., & UriCoV Working Group.
(2024). Mortality Risk and Urinary Proteome Changes in Acute COVID-19 Survivors in the Multinational CRIT-COV-U Study. Biomedicines, 12(9), 2090.
https://doi.org/10.3390/biomedicines12092090